Form D · Other Health Care

IRIDEX CORP

Mountain View, CA · CIK 0001006045

Offering snapshot reported Apr 3, 2026 · SEC filing

Reported sold: $10M
Investors reported: 1
Minimum accepted: $0
First sale: Mar 19, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 3, 2026	Amendment	$10,000,000	$0vs Apr 3, 2025	1	SEC filing
Apr 3, 2025	Initial	$10,000,000	No comparison	1	SEC filing

Offering details

Securities: Equity, Debt, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-542889

This filing is an annual amendment and no additional promissory notes have been issued since the date of first sale; however, the investor will have the right to purchase additional promissory notes in an aggregate principal amount of up to $10,000,000.

Source: Form D, filed Apr 3, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Huss Beverly	Director
Yu Hao Chen	Director
Romeo Dizon	Executive
Robert Grove	Director
Beverly Huss	Director
Ludlum Kenneth	Director
Patrick Mercer	Director, Executive
William Moore	Director
Scott Shuda	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

1212 Terra Bella Ave
Mountain View, CA, 94043